Literature DB >> 32197832

Continuing the search for a hormonal male contraceptive.

Fiona Yuen1, Brian T Nguyen2, Ronald S Swerdloff3, Christina Wang4.   

Abstract

This chapter discusses the mechanisms of action of hormonal male contraception, which suppresses the hypothalamic-pituitary-testis axis. When the intratesticular concentration of testosterone is subsequently suppressed to adequately low concentrations, spermatogenesis is arrested. Androgens are a necessary hormonal male contraceptive component because they not only suppress the hypothalamic-pituitary-testis axis, but also provide the male hormone necessary to maintain peripheral androgen functions. Past studies using testosterone alone and testosterone combined with progestins demonstrated contraceptive efficacy in the female partner at rates similar to combined hormonal female methods. Newer hormonal male contraceptive formulations and the alternative routes of administration are discussed, along with potential barriers, challenges, and opportunities for hormonal male contraceptive development. Novel methods that are safe, effective, reversible, user-friendly, and coitus-independent are intrinsic to equitably meet the various needs and limitations of an increasingly diverse population.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Acceptability; Androgens; Male contraception emerging market; Progestins; Spermatogenesis suppression

Mesh:

Substances:

Year:  2020        PMID: 32197832      PMCID: PMC7375909          DOI: 10.1016/j.bpobgyn.2020.02.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  61 in total

1.  Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men.

Authors:  B D Anawalt; M Y Roth; J Ceponis; V Surampudi; J K Amory; R S Swerdloff; P Y Liu; C Dart; W J Bremner; R Sitruk-Ware; N Kumar; D L Blithe; S T Page; C Wang
Journal:  Andrology       Date:  2019-04-10       Impact factor: 3.842

2.  USE OF MALE METHODS OF CONTRACEPTION WORLDWIDE.

Authors:  John Ross; Karen Hardee
Journal:  J Biosoc Sci       Date:  2016-11-28

Review 3.  Kinetics of spermatogenesis in mammals: seminiferous epithelium cycle and spermatogonial renewal.

Authors:  Y Clermont
Journal:  Physiol Rev       Date:  1972-01       Impact factor: 37.312

4.  Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men.

Authors:  H M Behre; B Klein; E Steinmeyer; G P McGregor; K Voigt; E Nieschlag
Journal:  J Clin Endocrinol Metab       Date:  1992-08       Impact factor: 5.958

5.  Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis.

Authors:  Peter Y Liu; Ronald S Swerdloff; Peter D Christenson; David J Handelsman; Christina Wang
Journal:  Lancet       Date:  2006-04-29       Impact factor: 79.321

6.  A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.

Authors:  Yi-Qun Gu; Xing-Hai Wang; Dwo Xu; Lin Peng; Li-Fa Cheng; Ming-Kong Huang; Zhen-Jia Huang; Gui-Yuan Zhang
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

7.  Contraceptive efficacy of a depot progestin and androgen combination in men.

Authors:  Leo Turner; Ann J Conway; Mark Jimenez; Peter Y Liu; Elise Forbes; Robert I McLachlan; David J Handelsman
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

8.  Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.

Authors:  C J Bagatell; A M Matsumoto; R B Christensen; J E Rivier; W J Bremner
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

Review 9.  Demand for male contraception.

Authors:  Emily Dorman; David Bishai
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2012-10       Impact factor: 2.217

10.  Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men.

Authors:  Hermann M Behre; Michael Zitzmann; Richard A Anderson; David J Handelsman; Silvia W Lestari; Robert I McLachlan; M Cristina Meriggiola; Man Mohan Misro; Gabriela Noe; Frederick C W Wu; Mario Philip R Festin; Ndema A Habib; Kirsten M Vogelsong; Marianne M Callahan; Kim A Linton; Doug S Colvard
Journal:  J Clin Endocrinol Metab       Date:  2016-10-27       Impact factor: 5.958

View more
  2 in total

1.  Blockade of GRTH/DDX25 Phosphorylation by Cyclic Peptides Provides an Avenue for Developing a Nonhormonal Male Contraceptive.

Authors:  Murugananthkumar Raju; Raghuveer Kavarthapu; Rajakumar Anbazhagan; Sergio A Hassan; Maria L Dufau
Journal:  J Med Chem       Date:  2021-10-02       Impact factor: 8.039

2.  Knowledge and Perception Regarding the Development and Acceptability of Male Contraceptives Among Pharmacists: A Mixed Sequential Method.

Authors:  Muna Barakat; Samar Thiab; Sara Thiab; Raja'a A Al-Qudah; Amal Akour
Journal:  Am J Mens Health       Date:  2022 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.